Reuters reports the FDA submitted the proposal for White House review on Oct 15, with a correction noting BPC-157 is among the so-called Wolverine peptides.
Recap by typeshit. Full story at Reuters on MSN.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
After advisers backed adding BPC-157, TB-500, KPV and others to the 503A bulks list, pharmacists are waiting on the FDA's final decision.
South Africa's medicines regulator now spells out how synthetic peptide medicines can be legally registered and sold, a first for the country.
Officers say the seized pharmaceuticals were worth $280,106.20 in total, part of a wider push against smuggled weight loss and peptide products.
The TRANSCEND-T2D-1 results in The Lancet covered 537 adults over 40 weeks, with HbA1c falling as much as 1.94 points at the top 12 mg dose versus placebo.
The GLP-1/GIP drug hit up to 19% mean weight loss over 48 weeks in a Chinese phase 3, with fewer GI side effects, Regeneron says. US trials are still ahead.
Loading…